Skip to content

Asset turnover at other companies

Baxter International logo
Baxter InternationalBAX
0.6×+0.1×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.4×0.0×
ADMA Biologics logo
ADMA BiologicsADMA
0.9×-0.2×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
1.3×+0.2×
Biodesix, Inc. logo
Biodesix, Inc.BDSX
1.1×+0.2×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
0.7×-0.1×

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Calculated from Lifecore Biomedical, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s asset turnover?
Lifecore Biomedical, Inc. (LFCR) reported asset turnover of 0.5× in Q1 2025.
How has Lifecore Biomedical, Inc.'s asset turnover changed year-over-year?
Lifecore Biomedical, Inc.'s asset turnover increased by 3.4% year-over-year, from 0.5× to 0.5×.
What is the long-term trend for Lifecore Biomedical, Inc.'s asset turnover?
Over 4 years (2021 to 2025), Lifecore Biomedical, Inc.'s asset turnover has grown at a 14.9% compound annual growth rate (CAGR), from 0.3× to 0.5×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.